Research published in Elsevier journals as early as June 2020 indicated that ivermectin could kill coronaviruses in a laboratory setting. Despite these findings, the drug has faced significant resistance from major health organizations and social media platforms, which have removed content promoting its use. The drug's long history of safety and low cost are cited as reasons for its potential as a global solution.



